Assyro AI
FDA 483 Database

FDA Form 483s Issued in June 2024

Every published Form FDA 483 issued in June 2024, drawn from the FDA OII FOIA Electronic Reading Room. Each row links to the FDA source record.

12

Published 483s in June 2024

12

Distinct firms

Form 483s issued in June 2024

Brands International CorporationFDA
FEI
3007389902
Issued
Jun 21, 2024
Establishment
OTC Drug Manufacturer
Location
Canada
Jubilant HollisterStier General PartnershipFDA
FEI
3001623073
Issued
Jun 14, 2024
Establishment
Sterile Drug Manufacturer
Location
Canada
AstraZeneca Pharmaceuticals LP Frederick Manufacturing CenterFDA
FEI
3002617771
Issued
Jun 7, 2024
Establishment
Active Pharmaceutical Ingredient Manufacturer
Location
USA
Mylan Laboratories Ltd.FDA
FEI
3010453141
Issued
Jun 26, 2024
Establishment
Finished Pharmaceutical Manufacturer
Location
India
Fagron Compounding Services, LLCFDA
FEI
3012104093
Issued
Jun 28, 2024
Establishment
Outsourcing Facility
Location
Kansas, United States
Hikma Injectables USA Inc.FDA
FEI
3022897129
Issued
Jun 25, 2024
Establishment
Outsourcing Facility
Location
New Jersey, United States
Carie Boyd PharmaceuticalsFDA
FEI
3010589333
Issued
Jun 21, 2024
Establishment
Outsourcing Facility
Location
Texas, United States
Biocon Biosphere LimitedFDA
FEI
3022125340
Issued
Jun 14, 2024
Establishment
Finished Pharmaceutical Manufacturer
Location
India
Hikma Pharmaceuticals USA Inc.FDA
FEI
2220525
Issued
Jun 12, 2024
Establishment
Outsourcing Facility
Location
New Jersey, United States
Torrent Pharmaceuticals LimitedFDA
FEI
3005029956
Issued
Jun 12, 2024
Establishment
Active Pharmaceutical Ingredient & Finished Dosage Manufacturer
Location
India
Cipla LimitedFDA
FEI
3004081307
Issued
Jun 21, 2024
Establishment
Finished Pharmaceutical Manufacturer
Location
India
Dr. Reddy's Laboratories Limited CTO -- Unit 6FDA
FEI
3002949085
Issued
Jun 7, 2024
Establishment
Active Pharmaceutical Ingredient Manufacturer
Location
India

Other months in 2024

Back to the FDA 483 Database